Canada markets closed

Santhera Pharmaceuticals Holding AG (SANN.SW)

Swiss - Swiss Delayed Price. Currency in CHF
Add to watchlist
9.31-0.06 (-0.64%)
At close: 05:30PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
5,162
7,473
-1,595
15,008
Cost of Revenue
3,645
3,592
3,767
10,431
Gross Profit
1,517
3,881
-5,362
4,577
Operating Expenses
Research Development
23,414
30,536
29,715
34,228
Selling General and Administrative
24,980
25,422
22,057
23,914
Total Operating Expenses
48,262
55,857
51,526
57,653
Operating Income or Loss
-46,745
-51,976
-56,888
-53,076
Interest Expense
19,852
20,189
16,423
6,891
Income Before Tax
-64,904
-70,616
-54,717
-67,456
Income Tax Expense
-216
460
809
203
Income from Continuing Operations
-64,688
-71,076
-55,526
-67,659
Net Income
-64,688
-71,076
-55,526
-67,659
Net Income available to common shareholders
-64,688
-71,076
-55,526
-67,659
Basic EPS
-8.63
-11.70
-16.20
-50.80
Diluted EPS
-8.63
-11.70
-16.20
-50.80
Basic Average Shares
8,837
6,093
3,417
1,332
Diluted Average Shares
8,837
6,093
3,417
1,332